WHO-UMC IDMP Management and Publish API
0.1.0 - CI Build
WHO-UMC IDMP Management and Publish API
0.1.0 - CI Build
WHO-UMC IDMP Management and Publish API, published by Uppsala Monitoring Centre. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Uppsala-Monitoring-Centre/WHO-UMC-IDMP-Service/ and changes regularly. See the Directory of published versions
<Task xmlns="http://hl7.org/fhir">
<id value="UK-emc-00001"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Task UK-emc-00001</b></p><a name="UK-emc-00001"> </a><a name="hcUK-emc-00001"> </a><a name="UK-emc-00001-en-US"> </a><p><b>status</b>: Draft</p><p><b>intent</b>: proposal</p><p><b>priority</b>: Routine</p><p><b>authoredOn</b>: 2024-01-17</p><p><b>lastModified</b>: 2024-01-17</p><blockquote><p><b>input</b></p><p><b>type</b>: <span title="Codes:{http://who-umc.org/idmp/CodeSystem/task-input-type mpd-request-resource}">Medicinal Product for PhPID request</span></p><p><b>value</b>: <a href="#hcUK-emc-00001/5d02cfc1-053f-4694-9ce8-d0ee6c658b72">MedicinalProductDefinition: identifier = http://medicines.org.uk/product#511; type = Medicinal Product; domain = Human use; status = Active; statusDate = 2020-08-03 15:11:41+0000; combinedPharmaceuticalDoseForm = Tablet and powder for oral solution; classification = methotrexate</a></p></blockquote><blockquote><p><b>input</b></p><p><b>type</b>: <span title="Codes:{http://who-umc.org/idmp/CodeSystem/task-input-type ingredient-request-resource}">Ingredient for PhPID request</span></p><p><b>value</b>: <a href="#hcUK-emc-00001/54c6c580-5b34-4032-9403-c9d2154ac073">Ingredient: status = active; role = Active</a></p></blockquote><blockquote><p><b>input</b></p><p><b>type</b>: <span title="Codes:{http://who-umc.org/idmp/CodeSystem/task-input-type organization-request-resource}">Test by Datapharm for PhPID request</span></p><p><b>value</b>: <a href="#hcUK-emc-00001/dti">Organization Datapharm Test Inc</a></p></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: MedicinalProductDefinition #5d02cfc1-053f-4694-9ce8-d0ee6c658b72</b></p><a name="UK-emc-00001/5d02cfc1-053f-4694-9ce8-d0ee6c658b72"> </a><a name="hcUK-emc-00001/5d02cfc1-053f-4694-9ce8-d0ee6c658b72"> </a><a name="UK-emc-00001/5d02cfc1-053f-4694-9ce8-d0ee6c658b72-en-US"> </a><p><b>identifier</b>: <code>http://medicines.org.uk/product</code>/511</p><p><b>type</b>: <span title="Codes:{http://hl7.org/fhir/medicinal-product-type MedicinalProduct}">Medicinal Product</span></p><p><b>domain</b>: <span title="Codes:{http://hl7.org/fhir/medicinal-product-domain Human}">Human use</span></p><p><b>status</b>: <span title="Codes:{http://hl7.org/fhir/publication-status active}">Active</span></p><p><b>statusDate</b>: 2020-08-03 15:11:41+0000</p><p><b>combinedPharmaceuticalDoseForm</b>: <span title="Codes:{http://hl7.org/fhir/combined-dose-form 100000074064}">Tablet and powder for oral solution</span></p><p><b>classification</b>: <span title="Codes:{http://www.whocc.no/atc L04AX03}">methotrexate</span></p><p><b>attachedDocument</b>: SPC/511</p><h3>Contacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Contact</b></td></tr><tr><td style="display: none">*</td><td><a href="#hcUK-emc-00001/dti">Organization Datapharm Test Inc</a></td></tr></table><blockquote><p><b>name</b></p><p><b>productName</b>: Methotrexate 2.5 mg Tablets</p><p><b>type</b>: <span title="Codes:">RegulatorApprovedName</span></p><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{urn:iso:std:iso:3166 GBR}">United Kingdom</span></td><td><span title="Codes:{urn:iso:std:iso:3166 GBR}">United Kingdom</span></td><td><span title="Codes:{urn:ietf:bcp:47 en}">English</span></td></tr></table></blockquote></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Ingredient #54c6c580-5b34-4032-9403-c9d2154ac073</b></p><a name="UK-emc-00001/54c6c580-5b34-4032-9403-c9d2154ac073"> </a><a name="hcUK-emc-00001/54c6c580-5b34-4032-9403-c9d2154ac073"> </a><a name="UK-emc-00001/54c6c580-5b34-4032-9403-c9d2154ac073-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: <a href="#hcUK-emc-00001/5d02cfc1-053f-4694-9ce8-d0ee6c658b72">MedicinalProductDefinition: identifier = http://medicines.org.uk/product#511; type = Medicinal Product; domain = Human use; status = Active; statusDate = 2020-08-03 15:11:41+0000; combinedPharmaceuticalDoseForm = Tablet and powder for oral solution; classification = methotrexate</a></p><p><b>role</b>: <span title="Codes:{http://hl7.org/fhir/ingredient-role 100000072072}">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://who-umc.org/idmp/gsid GSID23G92UMX93H45}">Methotrexate sodium</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Presentation[x]</b></td><td><b>TextPresentation</b></td></tr><tr><td style="display: none">*</td><td>2.5 milligram<span style="background: LightGoldenRodYellow"> (Details: UCUM codemg = 'mg')</span>/1 IU<span style="background: LightGoldenRodYellow"> (Details: Strength units applicable in the IDMP PhPID service codeIU = 'arbitrary international unit')</span></td><td>2.5 mg</td></tr></table></blockquote></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Organization #dti</b></p><a name="UK-emc-00001/dti"> </a><a name="hcUK-emc-00001/dti"> </a><a name="UK-emc-00001/dti-en-US"> </a><p><b>active</b>: true</p><p><b>type</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/organization-type bus}">Datapharm Test FCAT35</span></p><p><b>name</b>: Datapharm Test Inc</p></blockquote></div>
</text>
<contained>
<MedicinalProductDefinition>
<id value="5d02cfc1-053f-4694-9ce8-d0ee6c658b72"/>
<meta>
<profile
value="http://who-umc.org/idmp/StructureDefinition/MedicinalProductDefinition-who-php-req"/>
</meta>
<identifier>
<system value="http://medicines.org.uk/product"/>
<value value="511"/>
</identifier>
<type>
<coding>
<system value="http://hl7.org/fhir/medicinal-product-type"/>
<code value="MedicinalProduct"/>
</coding>
</type>
<domain>
<coding>
<system value="http://hl7.org/fhir/medicinal-product-domain"/>
<code value="Human"/>
</coding>
<text value="Human use"/>
</domain>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
</coding>
<text value="Active"/>
</status>
<statusDate value="2020-08-03T15:11:41Z"/>
<combinedPharmaceuticalDoseForm>
<coding>
<system value="http://hl7.org/fhir/combined-dose-form"/>
<code value="100000074064"/>
<display value="Tablet and powder for oral solution"/>
</coding>
<text value="Tablet and powder for oral solution"/>
</combinedPharmaceuticalDoseForm>
<classification>
<coding>
<system value="http://www.whocc.no/atc"/>
<code value="L04AX03"/>
</coding>
</classification>
<attachedDocument>
<display value="SPC/511"/>
</attachedDocument>
<contact>
<contact>
<reference value="#dti"/>
</contact>
</contact>
<name>
<productName value="Methotrexate 2.5 mg Tablets"/>
<type>
<coding>
<code value="RegulatorApprovedName"/>
</coding>
</type>
<usage>
<country>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="GBR"/>
</coding>
</country>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="GBR"/>
</coding>
</jurisdiction>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="en"/>
</coding>
</language>
</usage>
</name>
</MedicinalProductDefinition>
</contained>
<contained>
<Ingredient>
<id value="54c6c580-5b34-4032-9403-c9d2154ac073"/>
<meta>
<profile
value="http://who-umc.org/idmp/StructureDefinition/Ingredient-who-php"/>
</meta>
<status value="active"/>
<for>
<reference value="#5d02cfc1-053f-4694-9ce8-d0ee6c658b72"/>
</for>
<role>
<coding>
<system value="http://hl7.org/fhir/ingredient-role"/>
<code value="100000072072"/>
</coding>
<text value="Active"/>
</role>
<substance>
<code>
<concept>
<coding>
<system value="http://who-umc.org/idmp/gsid"/>
<code value="GSID23G92UMX93H45"/>
</coding>
<text value="Methotrexate sodium"/>
</concept>
</code>
<strength>
<presentationRatio>
<numerator>
<value value="2.5"/>
<unit value="milligram"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="IU"/>
<system
value="http://who-umc.org/idmp/CodeSystem/strengthUnit"/>
<code value="IU"/>
</denominator>
</presentationRatio>
<textPresentation value="2.5 mg"/>
</strength>
</substance>
</Ingredient>
</contained>
<contained>
<Organization>
<id value="dti"/>
<active value="true"/>
<type>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/organization-type"/>
<code value="bus"/>
</coding>
<text value="Datapharm Test FCAT35"/>
</type>
<name value="Datapharm Test Inc"/>
</Organization>
</contained>
<status value="draft"/>
<intent value="proposal"/>
<priority value="routine"/>
<authoredOn value="2024-01-17"/>
<lastModified value="2024-01-17"/>
<input>
<type>
<coding>
<system value="http://who-umc.org/idmp/CodeSystem/task-input-type"/>
<code value="mpd-request-resource"/>
<display value="Medicinal Product for PhPID request"/>
</coding>
<text value="Medicinal Product for PhPID request"/>
</type>
<valueReference>
<reference value="#5d02cfc1-053f-4694-9ce8-d0ee6c658b72"/>
</valueReference>
</input>
<input>
<type>
<coding>
<system value="http://who-umc.org/idmp/CodeSystem/task-input-type"/>
<code value="ingredient-request-resource"/>
<display value="Ingredient for PhPID request"/>
</coding>
<text value="Ingredient for PhPID request"/>
</type>
<valueReference>
<reference value="#54c6c580-5b34-4032-9403-c9d2154ac073"/>
</valueReference>
</input>
<input>
<type>
<coding>
<system value="http://who-umc.org/idmp/CodeSystem/task-input-type"/>
<code value="organization-request-resource"/>
<display value="Marketing Auth Holder for PhPID request"/>
</coding>
<text value="Test by Datapharm for PhPID request"/>
</type>
<valueReference>
<reference value="#dti"/>
</valueReference>
</input>
</Task>
IG © 2024+ Uppsala Monitoring Centre. Package idmp.who-umc.org.fhir#0.1.0 based on FHIR 5.0.0. Generated 2024-09-16
